MH 15E
Alternative Names: MH-15E; Morphine hydrochloride-extraduralLatest Information Update: 31 Dec 2021
At a glance
- Originator Daiichi Sankyo Company; Dainippon Sumitomo Pharma; Shionogi; Takeda; Tanabe Seiyaku
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer pain
Most Recent Events
- 03 Apr 2006 Daiichi Pharmaceutical has merged with Sankyo to form Daiichi Sankyo Inc
- 01 Oct 2005 Sumitomo Pharmaceuticals has merged with Dainippon Pharmaceutical to form Dainippon Sumitomo Pharma
- 31 Dec 2003 Registered for Cancer pain in Japan (Epidural injection)